Literature DB >> 26027878

Medication overuse and chronic migraine: a critical review according to clinical pharmacology.

Anna Ferrari1, Carlo Baraldi, Emilio Sternieri.   

Abstract

INTRODUCTION: Chronic migraine is often complicated by medication-overuse headache (MOH), a headache due to excessive intake of acute medications. Chronic migraine and MOH are serious and disabling disorders. Since chronic migraine derives from the progression of originally episodic migraine, the fundamental therapeutic strategy is prevention. This narrative review describes how to try to prevent the development of MOH and how to manage it once it has appeared. AREAS COVERED: A PubMed database search (from 1988 to January 2015) and a review of published studies on chronic migraine and MOH were conducted. EXPERT OPINION: In spite of progress in migraine treatment, the prevalence of chronic headaches and MOH has not changed in the course of time. Today, a large number of migraine patients have turned to numerous expert physicians and experienced all sorts of prophylactic treatments without decisive benefits. Their condition seems to have crystallized even more as chronic and intractable. This means that to prevent chronification and MOH, we need more effective drugs and better strategies to use them. In particular, we must detect disease biomarkers and predictive factors for drug response that allow for personalized treatment when migraine is still episodic and make analgesic overuse pointless.

Entities:  

Keywords:  chronic migraine; drug; headache; medication-overuse headache; migraine; prevention; prophylaxis; treatment

Mesh:

Substances:

Year:  2015        PMID: 26027878     DOI: 10.1517/17425255.2015.1043265

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  7 in total

1.  Single-blind, randomized, pilot study combining shiatsu and amitriptyline in refractory primary headaches.

Authors:  Veronica Villani; Luca Prosperini; Fulvio Palombini; Francesco Orzi; Giuliano Sette
Journal:  Neurol Sci       Date:  2017-03-10       Impact factor: 3.307

2.  An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.

Authors:  Natasa Gisev; Suzanne Nielsen; Elena Cama; Briony Larance; Raimondo Bruno; Louisa Degenhardt
Journal:  Eur J Clin Pharmacol       Date:  2015-12-22       Impact factor: 2.953

3.  Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study.

Authors:  Anna Ferrari; Carlo Baraldi; Manuela Licata; Daniele Vandelli; Filippo Marchesi; Federica Palazzoli; Patrizia Verri; Cecilia Rustichelli; Enrico Giuliani; Enrico Silingardi
Journal:  Eur J Clin Pharmacol       Date:  2016-05-31       Impact factor: 2.953

4.  Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up.

Authors:  Licia Grazzi; Emanuela Sansone; Alberto Raggi; Domenico D'Amico; Andrea De Giorgio; Matilde Leonardi; Laura De Torres; Francisco Salgado-García; Frank Andrasik
Journal:  J Headache Pain       Date:  2017-02-04       Impact factor: 7.277

Review 5.  From transformation to chronification of migraine: pathophysiological and clinical aspects.

Authors:  M Torres-Ferrús; F Ursitti; A Alpuente; F Brunello; D Chiappino; T de Vries; S Di Marco; S Ferlisi; L Guerritore; N Gonzalez-Garcia; A Gonzalez-Martinez; D Khutorov; M Kritsilis; A Kyrou; T Makeeva; A Minguez-Olaondo; L Pilati; A Serrien; O Tsurkalenko; D Van den Abbeele; W S van Hoogstraten; C Lampl
Journal:  J Headache Pain       Date:  2020-04-29       Impact factor: 7.277

Review 6.  Cupping Therapy for Migraine: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Jihye Seo; Hongmin Chu; Cheol-Hyun Kim; Kang-Keyng Sung; Sangkwan Lee
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-24       Impact factor: 2.629

7.  Migraine management: an update for the 2020s.

Authors:  Michael Eller; Shuli Cheng
Journal:  Intern Med J       Date:  2022-07       Impact factor: 2.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.